$2.25+0.22 (+10.84%)
At close: Nov 20, 2026, 4:00 PM ET· Nasdaq · USD
Evaxion (EVAX) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
7 figures withheld by our checks. Each blank figure names its reason.
Business engineChoppy: revenue history is too short to read a growth trend, net margin −63.5%.
The four lines that matter · FY21–FY25
Revenue ($M)▲23.4%
12.1
FY21→FY25CAGR —
Net income ($M)▲27.1%
−7.7
FY21→FY25CAGR —
Free cash flow ($M)—
−6.6
no value for 1 of 5 yearsCAGR —
Diluted EPS—
—
no FY25 valueCAGR —
What the receipts whisper · what a headline number hides
Share count
+0.0%
417.0mn → 417.0mn diluted shares since FY25. Broadly flat, so EPS moves with net income rather than with the share count.
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
-63¢ of every revenue dollar becomes profit.
Margin trend · direction beats level Operating Net
Net margin -63.5% is below the sector median. This filer reports no gross profit line, so that margin is not drawn.
The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
On the latest annual statement the reported earnings per share does not reconcile with net income to common shareholders divided by the reported share count (a factor of 5.959), so the two figures are on different bases. Both are shown as filed.
USD thousands except per-share & ratios
| Line item | FY25 † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 12,144.0 | 12,144.0 | 9,844.0 | 0.0 | 0.0 | 0.0 | ▲23.4% | — |
Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — |
Gross profit | — | —A | —A | 0.0 | 0.0 | 0.0 | — | — |
Research & development | 9,975.0 | 9,975.0 | 10,457.0 | 11,916.0 | 17,056.0 | 19,583.0 | ▼4.6% | −15.5% |
Selling, general & admin | 6,787.0 | 6,787.0 | 7,619.0 | 10,354.0 | 8,208.0 | 6,251.0 | ▼10.9% | +2.1% |
Total operating expenses | 16,762.0 | 16,762.0 | 18,076.0 | 22,270.0 | 25,264.0 | 25,917.0 | ▼7.3% | −10.3% |
Operating incomefeeds ROC rank | −4,618.0 | −4,618.0 | −8,232.0 | −22,197.0 | −25,264.0 | −25,834.0 | ▲43.9% | — |
Other income, net | −3,997.0 | −3,997.0 | −3,123.0 | −718.0 | 1,323.0 | 1,124.0 | — | — |
Pretax income | −8,615.0 | −8,615.0 | −11,355.0 | −22,915.0 | −23,941.0 | −24,710.0 | ▲24.1% | — |
Income tax | −908.0 | −908.0 | −788.0 | −790.0 | −772.0 | −178.0 | ▼15.2% | — |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | −7,707.0 | −7,707.0 | −10,567.0 | −22,125.0 | −23,169.0 | −24,532.0 | ▲27.1% | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | — | — | — | — | — | −6.30 | — | — |
Diluted shares (mn) | 417.01 | 417.01 | 70.13 | 37.90 | 24.14 | 23.20 | ▲494.6% | +105.9% |
| Margins | ||||||||
Gross margin | — | —A | —A | — | — | — | — | — |
Operating margin | −38.0% | −38.0% | −83.6% | — | — | — | ▲45.6pp | — |
Net margin12th pct in Healthcare | −63.5% | −63.5% | −107.3% | — | — | — | ▲43.9pp | — |
† FY25 = fiscal 2025, through 2025-12-31; the trailing year is not available.A Withheld: cost of revenue is not on file, so the gross margin is not measured.
3 more years of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-03-05 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Evaxion's revenue last fiscal year?
Evaxion reported revenue of $12.1M in fiscal 2025, up 23.4% from fiscal 2024.
What was Evaxion's net income?
Evaxion reported net income of −$7.7M in fiscal 2025, a net margin of −63.5%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

